このアイテムのアクセス数: 16

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
j.radonc.2025.110879.pdf3.23 MBAdobe PDF見る/開く
タイトル: Integration test of biaxially rotational dynamic-radiation therapy for nasopharyngeal carcinoma: Efficacy evaluation and dosimetric analysis
著者: Hiraoka, Shinya
Hirashima, Hideaki  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0003-1548-1970 (unconfirmed)
Nakamura, Mitsuhiro  kyouindb  KAKEN_id
Tanaka, Fumiya
Adachi, Hiroki
Ono, Yuka  kyouindb  KAKEN_id
Ono, Tomohiro
Nakashima, Ryota  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0001-5412-5843 (unconfirmed)
Nakajima, Aya  KAKEN_id  orcid https://orcid.org/0000-0002-5942-4647 (unconfirmed)
Mizowaki, Takashi  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0002-8135-8746 (unconfirmed)
キーワード: Non-coplanar VMAT
Coplanar VMAT
Head and neck
Nasopharyngeal carcinoma
BROAD-RT
発行日: Jun-2025
出版者: Elsevier BV
誌名: Radiotherapy and Oncology
巻: 207
論文番号: 110879
抄録: Background and Purpose: OXRAY is a new O-ring-shaped radiotherapy system delivering biaxially rotational dynamic-radiation therapy (BROAD-RT), a technique that enables non-coplanar volumetric-modulated arc therapy (VMAT) for large target volumes without requiring couch movement. The purpose of this study was to evaluate the benefits of BROAD-RT and to perform an integration test to confirm the plan deliverability and its accuracy from the treatment planning system to OXRAY for patients with nasopharyngeal carcinoma. Methods and Materials: We compared treatment plans for BROAD-RT and coplanar VMAT (COVMAT) created in RayStation for 15 patients with nasopharyngeal cancer using the Wilcoxon signed-rank test. P values less than 0.05 were considered statistically significant. Additionally, we confirmed the plan delivery accuracy of BROAD-RT from the treatment planning system to OXRAY; gamma passing rates (GPRs) and delivery time were evaluated. The criteria for pass and fail were ≥95 % at γ3%2 mm. Results: BROAD-RT significantly improved the homogeneity and conformity index of planning target volume and reduced dose volume indices compared with COVMAT in D₀.₀₃ [cc] for the brainstem, D₀.₀₃ [cc] for the left optic nerve, D₀.₀₃ [cc] for the brachial plexus, Dₘₑₐₙ for each submandibular gland, Dₘₑₐₙ for the oral cavity, and Dₘₑₐₙ for each parotid gland. All plans for BROAD-RT passed the integration test; the mean GPR (3 %/2 mm) was above 95 % and the median delivery time was 209 s. Conclusions: BROAD-RT delivered by OXRAY passed the integration test, and it demonstrated the potential benefit of improving the dose distribution compared with COVMAT for patients with nasopharyngeal carcinoma.
著作権等: © 2025 The Author(s). Published by Elsevier B.V.
This is an open access article under the CC BY license.
URI: http://hdl.handle.net/2433/294089
DOI(出版社版): 10.1016/j.radonc.2025.110879
PubMed ID: 40189151
出現コレクション:学術雑誌掲載論文等

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス Creative Commons